Stoke Therapeutics, Inc. short interest in 2025
In 2025, Stoke Therapeutics, Inc.'s disclosed short interest ran from 16.52% of shares outstanding on 15 Jan 2025 to 18.77% on 31 Dec 2025, a change of +2.25 percentage points. The year's high was 23.71% on 15 Apr 2025 and its low 16.31% on 15 Dec 2025, averaging 20.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.53 days on 15 Jul 2025. Full history: Stoke Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 16.52% (15 Jan 2025)
- End of year
- 18.77% (31 Dec 2025)
- Change
- +2.25 pp
- High
- 23.71% (15 Apr 2025)
- Low
- 16.31% (15 Dec 2025)
- Average
- 20.28%
- Highest days to cover
- 23.53 (15 Jul 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 16.52% | 7.70 | |
| 31 Jan 2025 | 16.97% | 15.20 | |
| 14 Feb 2025 | 19.04% | 13.06 | |
| 28 Feb 2025 | 21.10% | 11.87 | |
| 14 Mar 2025 | 22.11% | 19.60 | |
| 31 Mar 2025 | 22.82% | 10.95 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 23.71% | 13.27 | |
| 30 Apr 2025 | 23.52% | 14.92 | |
| 15 May 2025 | 21.38% | 15.38 | 10-Q filed, results (8-K) |
| 30 May 2025 | 22.03% | 20.89 | |
| 13 Jun 2025 | 22.18% | 22.08 | |
| 30 Jun 2025 | 21.13% | 18.15 | |
| 15 Jul 2025 | 21.06% | 23.53 | |
| 31 Jul 2025 | 20.86% | 11.91 | |
| 15 Aug 2025 | 20.42% | 12.72 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 19.60% | 11.56 | |
| 15 Sep 2025 | 20.78% | 11.83 | |
| 30 Sep 2025 | 19.68% | 9.56 | |
| 15 Oct 2025 | 19.77% | 6.85 | |
| 31 Oct 2025 | 18.67% | 9.53 | |
| 14 Nov 2025 | 19.69% | 8.31 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 18.48% | 10.90 | |
| 15 Dec 2025 | 16.31% | 9.65 | |
| 31 Dec 2025 | 18.77% | 14.08 |
See also: Stoke Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.